| Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat CR Tate, LV Rhodes, HC Segar, JL Driver, FN Pounder, ME Burow, ... Breast Cancer Research 14 (3), 1-15, 2012 | 298 | 2012 |
| Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer LV Rhodes, SP Short, NF Neel, VA Salvo, Y Zhu, S Elliott, Y Wei, D Yu, ... Cancer research 71 (2), 603-613, 2011 | 179 | 2011 |
| Endocrine disruptor regulation of microRNA expression in breast carcinoma cells SL Tilghman, MR Bratton, HC Segar, EC Martin, LV Rhodes, M Li, ... PloS one 7 (3), e32754, 2012 | 178 | 2012 |
| Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer LV Rhodes, EC Martin, HC Segar, DFB Miller, A Buechlein, DB Rusch, ... Oncotarget 6 (18), 16638, 2015 | 128 | 2015 |
| Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators LV Rhodes, CR Tate, HC Segar, HE Burks, TB Phamduy, V Hoang, ... Breast cancer research and treatment 145, 593-604, 2014 | 98 | 2014 |
| The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells LV Rhodes, AM Nitschke, HC Segar, EC Martin, JL Driver, S Elliott, ... Oncology reports 27 (1), 10-16, 2012 | 85 | 2012 |
| Identification of the Potent Phytoestrogen Glycinol in Elicited Soybean (Glycine max) SM Boué, SL Tilghman, S Elliott, MC Zimmerman, KY Williams, ... Endocrinology 150 (5), 2446-2453, 2009 | 61 | 2009 |
| The Organochlorine o,p’-DDT Plays a Role in Coactivator-Mediated MAPK Crosstalk in MCF-7 Breast Cancer Cells MR Bratton, DE Frigo, HC Segar, KP Nephew, JA McLachlan, TE Wiese, ... Environmental health perspectives 120 (9), 1291-1296, 2012 | 45 | 2012 |
| Stable inhibition of specific estrogen receptor α (ERα) phosphorylation confers increased growth, migration/invasion, and disruption of estradiol signaling in MCF-7 breast … BP Huderson, TT Duplessis, CC Williams, HC Seger, CG Marsden, ... Endocrinology 153 (9), 4144-4159, 2012 | 39 | 2012 |
| Dual role of MEK1/2 and MEK5 in the reversal of epithelial-to-mesenchymal transition VT Hoang, S Elliott, EC Martin, LV Rhodes, HC Segar, H Burks, ... Cancer Research 74 (19_Supplement), 1052-1052, 2014 | | 2014 |
